RWE Decision Alerts provide subscribers with timely analyses of published reports from HAS, AEMPS, NICE, EMA, and the FDA where RWE is used to support HTA and regulatory decision-making. We identify if a submission included RWE and assess the value of the RWE submitted. Subscribe to receive updates that help you stay current on the RWE landscape.
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.